EcoDrugPlus

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2a

Ensembl ID : ENSEBUG00000010716
Gene Symbol: SRD5A2A
1 Cross references
266 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSEBUG00000009344
Gene Symbol: TBXAS1
1 Cross references
220 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSEBUG00000016751
Gene Symbol: TYMS
1 Cross references
225 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSEBUG00000002548
Gene Symbol: TLR7
1 Cross references
196 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSEBUG00000002168
Gene Symbol: TPH1A
1 Cross references
258 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSEBUG00000012267
Gene Symbol: TH
1 Cross references
294 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSEBUG00000008228
Gene Symbol: UTS2R
1 Cross references
97 Possible Orthologues:

V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog

Ensembl ID : ENSEBUG00000015012
Gene Symbol: KRAS
1 Cross references
235 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSEBUG00000002817
Gene Symbol: VKORC1
1 Cross references
191 Possible Orthologues:

Zgc:171772

Ensembl ID : ENSEBUG00000005627
Gene Symbol: ZGC:171772
1 Cross references
423 Possible Orthologues:

Ensembl ID : ENSEBUG00000004704
Gene Symbol: -
Cross references: -
743 Possible Orthologues:

Ensembl ID : ENSEBUG00000004099
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).